View Item 

Show simple item record

Factor XIIIa-positive dermal dendritic cells and HLA-DR expression in radial versus vertical growth-phase melanomas

dc.contributor.authorFullen, Douglas R.en_US
dc.contributor.authorHeadington, John T.en_US
dc.date.accessioned2010-06-01T18:59:47Z
dc.date.available2010-06-01T18:59:47Z
dc.date.issued1998-11en_US
dc.identifier.citationFullen, Douglas R.; Headington, John T. (1998). "Factor XIIIa-positive dermal dendritic cells and HLA-DR expression in radial versus vertical growth-phase melanomas." Journal of Cutaneous Pathology 25(10): 553-558. <http://hdl.handle.net/2027.42/72186>en_US
dc.identifier.issn0303-6987en_US
dc.identifier.issn1600-0560en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72186
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=9870675&dopt=citationen_US
dc.format.extent2762535 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1998 Munksgaarden_US
dc.titleFactor XIIIa-positive dermal dendritic cells and HLA-DR expression in radial versus vertical growth-phase melanomasen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelDermatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan Hospitals, Ann Arbor, Michigan, USAen_US
dc.identifier.pmid9870675en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72186/1/j.1600-0560.1998.tb01740.x.pdf
dc.identifier.doi10.1111/j.1600-0560.1998.tb01740.xen_US
dc.identifier.sourceJournal of Cutaneous Pathologyen_US
dc.identifier.citedreferenceHeadington, JT. The dermal dendrocyte. In: Callen JP, Dahl MV, Goletz LE et al., eds. Advances in Dermatology. Chicago: Year Book Medical Publisher Inc., Vol. 1. 1986: 159.en_US
dc.identifier.citedreferenceSontheimer RD, Matsubara T, Seelig LL. A macrophage phenotype for a constitutive, class II anligen-presenting, human dermal perivascular dendritic cell. J Invest Dermatol 1989: 93: 154.en_US
dc.identifier.citedreferenceCerio R, Griffiths CE, Cooper KD, Nickoloff BJ, Headington JT. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol 1989: 121: 421.en_US
dc.identifier.citedreferenceEstrada JA, PiÉrard GE. Factor-XIIIa-positive dendrocytes and the dermal microvascular unit. Dermatologica 1990: 180: 51.en_US
dc.identifier.citedreferenceDerrick EK, Barker JN, Khan A, Price ML, MacDonald DM. The tissue distribution of factor XIIIa positive cells. Histopathology 1993: 22: 157.en_US
dc.identifier.citedreferenceCerio R, Spaull J, Wilson Jones E. Identification of factor XIIIa in cutaneous tissue [Letter]. Histopathology 1988: 13: 362.en_US
dc.identifier.citedreferenceHeadington JT, Cerio R. Dendritic cells and the dermis. Am J Dermatopathol 1990: 12: 217.en_US
dc.identifier.citedreferenceCerio R, Spaull J, Wilson Jones E. Histiocytoma cutis: a tumour of dennal dendrocytes (dermal dendrocytoma). Br J Dermatol 1989: 120: 197.en_US
dc.identifier.citedreferenceNemeth AJ, Penneys NS, Bernstein HB. Fibrous papule: a tumor of fibrohistiocytic cells that contain factor XIIIa. J Am Acad Dermatol 1988: 19: 1102.en_US
dc.identifier.citedreferenceGray MH, Trimble CL, Zirn J, McNutt NS, Smoller BR, Varghese M. Relationship of factor XIIIa-positlve dermal dendrocytes to Kaposi's sarcoma. Arch Pathol Lab Med 1991: 115: 791.en_US
dc.identifier.citedreferenceDenton KJ, Cotton DW, Wright A, Hird P. Factor XIIIa in nodular malignant melanoma and Spitz naevi. Br J Dermatol 1990: 123: 783.en_US
dc.identifier.citedreferenceNestle FO, Zheng XG, Thompson CB, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol 1993: 151: 6535.en_US
dc.identifier.citedreferenceRuiter DJ, Bhan AK, Harrist TJ, Sober AJ, Mihm MC. Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma. J Immunol 1982: 129: 2808.en_US
dc.identifier.citedreferencevan Vreeswijk H, Ruiter DJ, BrÖcker EB, Welvaart K, Ferrone S. Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma. J Invest Dermatol 1988: 90: 755.en_US
dc.identifier.citedreferenceZaloudik J, Moore M, Ghosh AK, Mechl Z, Rejthar A. DNA content and MHC class II antigen expression in malignant melanoma: clinical course. J Clin Pathol 1988: 41: 1078.en_US
dc.identifier.citedreferenceBecker JC, Brocker EB. Lymphocyte melanoma interaction: role of surface molecules. Recent Results Cancer Res 1995: 139: 205.en_US
dc.identifier.citedreferenceBrÖcker EB, Suter L, Sorg C. HLA-DR antigen expression in primary melanomas of the skin. J Invest Dermatol 1984: 82: 244.en_US
dc.identifier.citedreferenceHoltzmann B, BrÖcker EB, Lehman JM, et al. Tumor progression in human melanoma: five stages defined by their antigenic phenotypes. Int J Cancer 1987: 39: 466.en_US
dc.identifier.citedreferenceBrogelli L, Moretti S, Giannotti B. Superficial spreading melanoma with a nodular area: antigenic phenotype of the radial and vertical growth areas. Tumori 1989: 75: 8.en_US
dc.identifier.citedreferenceToriyama K, Wen DR, Paul E, Cochran AJ. Variations in the distribution, frequency, and phenotype of Langerhans cells during the evolution of malignant melanoma of the skin. J Invest Dermatol 1993: 100: 269s.en_US
dc.identifier.citedreferenceGarcia-Plata D, Lessana-Leibowitch M, Palangie A, et al. Immunophenotype analysis of dendritic cells and lymphocytes associated with cutaneous malignant melanomas. Invasion Metastasis 1995: 15: 125.en_US
dc.identifier.citedreferenceElder DE, Guerry D IV, Van Horn M, et al. The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51–3.99 mm). Cancer 1985: 56: 413.en_US
dc.identifier.citedreferenceClark WH Jr, Elder DE, Guerry D IV, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989: 81: 1893.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-0560.1998.tb01740.x.pdf
Size:
2.634MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.